PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14755007-1	2004	NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1"-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester] is an NO-releasing flurbiprofen derivative that also contains a ferulic acid (antioxidant) moiety.	Flurbiprofen	144-156	T cell leukemia, homeobox 2	Mus musculus	0-3	
17137722-1	2007	Vaccination with Abeta(1-42) and treatment with NCX-2216, a novel nitric oxide releasing flurbiprofen derivative, have each been shown separately to reduce amyloid deposition in transgenic mice and have been suggested as potential therapies for Alzheimer"s disease.	Flurbiprofen	89-101	T cell leukemia, homeobox 2	Mus musculus	48-51	
14755007-8	2004	NCX-2216 substantially inhibited prostanoid synthesis despite not being detectable in plasma and despite producing only low amounts of flurbiprofen in plasma and in the brain.	Flurbiprofen	135-147	T cell leukemia, homeobox 2	Mus musculus	0-3